Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 4—April 2014

Research

Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013

Benjamin Meyer, Marcel A. Müller, Victor M. Corman, Chantal B.E.M. Reusken, Daniel Ritz, Gert-Jan Godeke, Erik Lattwein, Stephan Kallies, Artem Siemens, Janko van Beek, Jan F. Drexler, Doreen Muth, Berend-Jan Bosch, Ulrich Wernery, Marion P.G. Koopmans, Renate Wernery, and Christian DrostenComments to Author 
Author affiliations: University of Bonn Medical Centre, Bonn, Germany (B. Meyer, M.A. Müller, V.M. Corman, D. Ritz, S. Kallies, A. Siemens, J.F. Drexler, D. Muth, C. Drosten); National Institute for Public Health and the Environment, Bilthoven, the Netherlands. (C.B.E.M. Reusken, G.-J. Godeke, J. van Beek, M.P.G. Koopmans); Erasmus Medical Centre, Rotterdam, the Netherlands (C.B.E.M. Reusken, J.F. Drexler, M.P.G. Koopmans); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Utrecht University, Utrecht, the Netherlands (B.-J. Bosch); Central Veterinary Research Laboratory, Dubai, United Arab Emirates (U. Wernery, R. Wernery)

Main Article

Table 3

BCoV neutralization test results for MERS-CoV–positive dromedary serum samples, United Arab Emirates, 2003 and 2013*

Collection
No. BCoV positive/no. MERS-CoV positive (serum dilution, %)
640–1,280
>1,280
1A 15/74 (20.3) 14/79 (17.7)
1B 0 0
2 0/3 (0.0) 14/42 (33.3)
3 2/13 (15.4) 52/182 (28.6)
4
6/30 (20.0)
14/86 (16.3)
Total 23/120 (19.2) 94/389 (24.2)

*BCoV, bovine coronavirus; MERS-CoV, Middle East respiratory syndrome coronavirus.

Main Article

TOP